Denmark
· Delayed Price · Currency is DKK ViroGates Company Description
ViroGates A/S, an in vitro diagnostics company, develops and sells blood tests for measuring chronic inflammation for the healthcare sector.
It offers suPARnostic, a proprietary biomarker used in hospital clinics to guide and inform individuals of their health state, and in hospitals to support clinical decisions and identify high-risk patients, as well as used for a range of acute and chronic health issues, such as cardiovascular disease, type 2 diabetes, and cancer.
The company’s product includes suPARnostic TurbiLatex, a latex particle-enhanced turbidimetric immunoassay that quantitatively determines the soluble urokinase plasminogen activator receptor (suPAR) level in human K2-EDTA- or lithium heparin plasma samples; suPARnostic ELISA that provides fully quantitative results; and suPARnostic Quick Triage kit for use in the point of care situation for early warning and patient triaging that allows clinicians and nurses to obtain a fast patient prognosis for patient disease severity, progression, and outcome.
ViroGates A/S was founded in 2000 and is headquartered in Birkerød, Denmark.
| Country | Denmark |
| Founded | 2000 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 10 |
| CEO | Jakob Knudsen |
Contact Details
Address: Banevaenget 13 Birkerød, 3460 Denmark | |
| Phone | 45 21 13 13 36 |
| Website | virogates.com |
Stock Details
| Ticker Symbol | VIRO |
| Exchange | Copenhagen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | DKK |
| ISIN Number | DK0061030574 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Jakob Knudsen | Chief Executive Officer |
| Dr. Jesper Eugen-Olsen | Co-Founder and Chief Scientific Officer |
| Josephine Baum Jorgensen | Chief Financial Officer |
| May Britt Dyvelkov | Vice President of Accounting |
| Thomas Krarup | Vice President of Global Sales and Marketing |